2025³â 03¿ù 07ÀÏ ±Ý¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > ´º½ºÁö´åÄÄ > Science & Technology

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýÈ°

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óÇ°

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
- - - - - - -
 

New Study Finds That Masimo PVi¢ç May Be Useful in Helping ER Doctors Determine the Severity of Asthma Attacks in Pediatric Patients

Researchers Said Masimo PVi Can Be Used As a ¡°Noninvasive, Rapid, and Objective Tool¡± for Helping Clinicians Predict Response to Treatment and Follow Up in Children with Obstructive Respiratory Disease
´º½ºÀÏÀÚ: 2022-05-24



NEUCHATEL, SWITZERLAND-- May 24, 2022 -- Masimo (NASDAQ: MASI) today announced the findings of a retrospective study published in the American Journal of Emergency Medicine in which Dr. Gülsah Demir and colleagues at Tepecik Research and Training Hospital in Izmir, Turkey investigated the potential ability of Masimo PVi® to guide emergency room triage decisions for pediatric patients with signs of obstructive respiratory disease, such as an asthma attack. PVi, or pleth variability index, is a noninvasive measurement of changes in perfusion index that occur during one or more respiratory cycles. The researchers concluded that “Automatic PVi measurement can be used as a noninvasive, rapid, and objective tool in the emergency department triage of patients admitted to the pediatric emergency department with signs of asthma attack or reactive respiratory tract disease.”[1]

Acute asthma attack is a common cause of admission to emergency departments (EDs) among children, and triage by severity is important for determining appropriate clinical treatment.[2,3] Noting that PVi has been shown to be an accurate method for measuring the degree of pulsus paradoxus,[4,5] a reduction in systolic blood pressure associated with obstructive respiratory tract disease, the authors sought to understand whether PVi might be of assistance to ED clinicians needing to make rapid triage decisions in such cases. They enrolled 133 patients between the ages of 2 and 18 (median age 5 years old) who arrived at the ED between May 2020 and July 2021 with a diagnosis of asthma attack or reactive respiratory tract disease. During initial examination and after treatment, patients’ PVi levels were measured using Masimo Radical-7® Pulse CO-Oximeters®. Severity of the asthma attack/respiratory disease was graded using the Pulmonary Index Score (PIS). Treatment decisions, including to hospitalize or to discharge, were made by clinicians who were blinded to PVi values.

The researchers found that PVi values, both before and after treatment, were significantly higher in patients with “severe” disease, compared to “mild” or “moderate” disease (p < 0.001): “Severe” patients had median PVi values of 47% (42 - 51) before treatment and 38% (32 - 44) after treatment; “moderate” patients, 31.5% (26 - 39) before and 25% (20 - 29) after; and “mild” patients, 24% (19 - 27) before and 19.5% (17 - 22) after. PVi values were also significantly higher for patients who were hospitalized, compared to those who were discharged from the ED (p < 0.001): Hospitalized patients had median PVi values of 46.5% (39 - 49) before treatment and 38% (29 - 44) after treatment; discharged patients, 26% (22 - 34) before and 21% (18 - 26) after. For all severity levels, post-treatment PVi values were significantly lower than pre-treatment values (p < 0.001). The researchers calculated a pre-treatment PVi cut-off level of 37.5% for predicting whether a patient had “severe” disease (68.75% positive predictive power, with 100% sensitivity and 85% specificity, p < 0.001) and would require hospitalization (72.34% positive predictive power, with 91.89% sensitivity and 71.74% specificity, p < 0.001).

The authors concluded, “The severity of attacks of many patients who apply to the pediatric emergency department because of an attack due to obstructive respiratory tract diseases can be accurately defined with certain clinical evaluation tools. Although PIS is a very important tool for assessing attack severity, it includes some subjective parameters. Automatic PVi measurement can be useful in intensive emergency department conditions, especially in triage, in terms of predicting the response of patients to treatment and follow-up results by quickly determining the severity of attacks, and in terms of reducing subjective clinical decision variations among physicians. This is because it provides objective data.”

In the U.S., PVi is cleared as a noninvasive, dynamic indicator of fluid responsiveness in select populations of mechanically ventilated adult patients.



 Àüü´º½º¸ñ·ÏÀ¸·Î

Autel Energy Debuts Ultra-Fast MaxiCharger DH480 at EVCharge Live Thailand 2025
Dolce & Gabbana¡¯s $1M Glass Suit Fractionalization by Fermion launches the Future of Luxury Ownership
GIGABYTE Showcases Comprehensive AI Computing Portfolio at MWC 2025
Esri Advances Secure Drone Solutions with Blue UAS Cleared, Federally Approved Drone
SES and Quvia to Codevelop New-Generation Multi-Orbit Solutions to Enhance Quality of Experience
NTT DATA and Palo Alto Networks Enhance Private 5G Security for Industrial Deployments
Lenovo Pioneers More Personalized, Integrated, and Innovative Hybrid AI Technology at MWC 2025

 

CareDx Announces Study Showing AlloSeq cfDNA Highly Accurate in Detect...
ICC Arbitral Tribunal Rules in Favor of AOP Health in Arbitration Proc...
Geothermal Developer Ignis H2 Energy Raises $12.5M in Series A First C...
UL Solutions Reinforces Leadership in Fire Safety with New, Upgraded G...
Energy Vault Begins Construction of Battery Energy Storage Deployment ...
NTT DATA Launches Smart AI Agent to Accelerate Generative AI Adoption ...
Ferrer is the Highest-performing Pharmaceutical Company in the World f...

 


°øÁö»çÇ×
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â 'ä¹××尔'
¾Ë¸®¿ìºê Alliuv Áß¹® Ç¥±â 'ä¹联备'
¿À½ºÇÁ·Ò Ausfrom Áß¹® Ç¥±â 奥ÞÙÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom Áß¹® Ç¥±â 额ÒöÜØÙÌ
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
´º½º±×·ì Á¤º¸ ¹Ìµð¾î ºÎ¹® »óÇ¥µî·Ï
¾ËÇÁ·Ò °è¿­ »óÇ¥, »óÇ¥µî·Ï ¿Ï·á

 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æħ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇÑ°è¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, Æѽº 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..